Effects of the cannabinoid antagonist SR141716 (rimonabant) and d-amphetamine on palatable food and food pellet intake in non-human primates
- 1 April 2007
- journal article
- Published by Elsevier in Pharmacology Biochemistry and Behavior
- Vol. 86 (4) , 766-773
- https://doi.org/10.1016/j.pbb.2007.03.004
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- “Tasting and wasting” behavior in non-human primates: Aberrant behavior or normal behavior in “times of plenty”Physiology & Behavior, 2006
- Endogenous cannabinoids in the brain and peripheral tissues: regulation of their levels and control of food intakeInternational Journal of Obesity, 2006
- The CB1 receptor antagonist rimonabant reverses the diet‐induced obesity phenotype through the regulation of lipolysis and energy balanceThe FASEB Journal, 2005
- Motivational Effects of Cannabinoids and Opioids on Food Reinforcement Depend on Simultaneous Activation of Cannabinoid and Opioid SystemsNeuropsychopharmacology, 2005
- Pharmacokinetic factors in sex differences in Δ9-tetrahydrocannabinol-induced behavioral effects in ratsBehavioural Brain Research, 2004
- Behavioral models of binge-type eatingPhysiology & Behavior, 2004
- Effects of amphetamine, dexfenfluramine, diazepam, and dietary manipulations on responding reinforced by stimuli paired with food in nonhuman primatesPharmacology Biochemistry and Behavior, 2004
- Effects of SR141716A on Ethanol and Sucrose Self‐AdministrationAlcohol, Clinical and Experimental Research, 2001
- Effects of limited access to a fat option on food intake and body composition in female ratsInternational Journal of Eating Disorders, 2000
- Cocaine Pharmacokinetics in Men and in Women During the Follicular and Luteal Phases of the Menstrual CycleNeuropsychopharmacology, 1999